GPR22 and myocardial infarction: The present study, utilizing a transgenic mouse model, further indicated an increased expression of GPR22 in cardiomyocytes and showed that upregulating its downstream signaling pathways could ameliorate myocardial injury following acute myocardial infarction (AMI).